Search Count: 12
 |
Human Cdk8/Cyclin-C Complex With Inhibitor 2-9
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.57 Å Release Date: 2025-01-22 Classification: TRANSCRIPTION Ligands: EDO, GOL, A1IS8, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: EDO, GOL, A1IS8, DMS
 |
Human Cdk8/Cyclin-C Complex With Inhibitor 3-7
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2025-01-22 Classification: TRANSCRIPTION Ligands: CL, EDO, GOL, A1ITF, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: CL, EDO, GOL, A1ITF, DMS
 |
C-Terminal Bromodomain Of Human Brd2 With N-Ethyl-2-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-6-(1-Phenylethyl)Isonicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2021-04-07 Classification: NUCLEAR PROTEIN Ligands: UME, EDO, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-04-07
Ligands: UME, EDO, PEG
 |
C-Terminal Bromodomain Of Human Brd2 With 3-(2-(Benzyloxy)Phenyl)-5-Methyl-1H-1,2,4-Triazole
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULB |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-03-24
Ligands: EDO, PE4, ULB
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-N-Ethyl-3-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-4-(1-Phenylethoxy)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, UL8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-03-24
Ligands: EDO, UL8
 |
C-Terminal Bromodomain Of Human Brd2 With N-Ethyl-3-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-4-(Pyridin-2-Ylmethoxy)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, UM5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-03-24
Ligands: EDO, UM5
 |
C-Terminal Bromodomain Of Human Brd2 With 2-Benzyl-N-Cyclopropyl-6-(1-Methyl-1H-1,2,3-Triazol-4-Yl)Isonicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: UMB, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-03-24
Ligands: UMB, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With 2-Benzyl-N-Cyclopropyl-6-(1-Methyl-1H-1,2,3-Triazol-4-Yl)Isonicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: UM8, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-03-24
Ligands: UM8, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With 1-Benzyl-N-Methyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2020-08-05 Classification: TRANSCRIPTION Ligands: EDO, QCW, MES |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-08-05
Ligands: EDO, QCW, MES
 |
C-Terminal Bromodomain Of Human Brd2 With Gsk620
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2020-08-05 Classification: TRANSCRIPTION Ligands: EDO, QCZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-08-05
Ligands: EDO, QCZ
 |
C-Terminal Bromodomain Of Human Brd2 With Gsk549
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2020-08-05 Classification: TRANSCRIPTION Ligands: EDO, QD5, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-08-05
Ligands: EDO, QD5, PEG
 |
N-Terminal Bromodomain Of Human Brd4 With Gsk620
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2020-08-05 Classification: TRANSCRIPTION Ligands: EDO, 1PE, QCZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-08-05
Ligands: EDO, 1PE, QCZ